19 C
New York
Friday, June 9, 2023

The Oncology Institute Inc. (NASDAQ: TOI) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for The Oncology Institute Inc. (TOI) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $0.43. The The Oncology Institute Inc. has recorded 1,874 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance.

<25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


Stocks Info

The Oncology Institute Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Care Facilities industry. At the end of the last regular session, the stock closed at $0.43 and fluctuated between $0.4650 as its day high and $0.4210 as its day low. The current market capitalization of The Oncology Institute Inc. is $32.31M. A total of 0.6 million shares were traded on the day, compared to an average of 188.26K shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, TOI has seen 19 BUY and 0 SELL insider trades, representing the acquisition of 728,644 and the disposition of 0 shares. Over the last 12 months, there were 41 BUYs and 73 SELLs from insiders. Insiders purchased 1,656,484 shares during that period but sold 2,349,615.

In the most recent transaction, BARASCH RICHARD A bought 50,000 shares of TOI for 0.55 per share on Mar 17. After the transaction, the Director now owns 257,193 company shares. In a previous transaction on Dec 16, Miller Matthew P bought 73,684 shares at 0.95 per share. TOI shares that Chief Operating Officer owns now total 175,325.

Among the insiders who sold shares, Kaushal Mohit disposed of 15,994 shares on Nov 14 at a per-share price of $2.13. This resulted in the Director holding 25,534 shares of TOI after the transaction. In another insider transaction, Havencrest Healthcare Partners sold 365,321 shares at $2.33 per share on Nov 11. Company shares held by the 10% Owner now total 13,362,873.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for TOI in the last 3 months, the mean price target is $4.50 with high estimates of $6.00 and low estimates of $3.00. In terms of 52-week highs and lows, TOI has a high of $9.53 and a low of $0.41.

As of this writing, TOI has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0. The company reported an EPS of -$0.25 in the last quarter, which was -38.90% lower than expectations of -$0.18.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TOI’s latest balance sheet shows that the firm has $114.30M in Cash & Short Term Investments as of fiscal 2021. There were $183.00k in debt and $29.80M in liabilities at the time. Its Book Value Per Share was $1.34, while its Total Shareholder’s Equity was $104.16M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TOI is Buy with a score of 4.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles